BG Medicine Inc Announces Closing Of Public Offering And Exercise Of Over-Allotment Option

BG Medicine Inc announced that the closing of its previously announced public offering of 6,000,000 shares of its common stock, as well as 900,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriter. The shares were sold at the public offering price of $2.00 per share and the Company estimates the aggregate net proceeds to the Company will be approximately $12.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses. Lazard Capital Markets LLC acted as the sole book-running manager for the offering.